Targetable drivers in non-small cell lung cancer include ALK, RET, and ROS1 fusions—do you know how to detect them? DNA-based and RNA-based sequencing each have advantages and drawbacks when it comes to fusion detection. In this webinar, expert speakers will present their perspectives on fusion detection using next-generation sequencing in NSCLC.
Fusion Detection in Advanced NSCLC: Stay Up to Date
